The authorisation covers all OTC derivatives and futures products currently cleared by CME Clearing Europe. CME Clearing Europe lists a broad range of OTC and exchange traded derivatives, including interest rate swaps, energy and commodities, and FX contracts for clearing and provides services for CME Europe, CME Group’s London-based derivatives exchange.
CME Clearing Europe’s CCP authorisation follows the announcement that CME Group’s European clearing house is the first central counterparty (CCP) globally to offer the full segregation client protection model with enhanced protection for all bankruptcy scenarios. The full segregation model is notable in that it expands client asset protection beyond European Market Infrastructure Regulation (EMIR) requirements.
As the world’s leading and most diverse derivatives marketplace, CME Group (www.cmegroup.com) is where the world comes to manage risk. CME Group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate. CME Group brings buyers and sellers together through its CME Globex electronic trading platform and its trading facilities in New York and Chicago. CME Group also operates CME Clearing, one of the world’s leading central counterparty clearing providers, which offers clearing and settlement services across asset classes for exchange-traded contracts and over-the-counter derivatives transactions. These products and services ensure that businesses everywhere can substantially mitigate counterparty credit risk.
